This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

The Effect of Proprioception of Platelet Rich Plasma for Patients With Ankle Sprain

Sponsored by National Defense Medical Center, Taiwan

About this trial

Last updated 2 years ago

Study ID

Tri-Service General Hospital

Status

Recruiting

Type

Interventional

Phase

Phase 4

Placebo

No

Accepting

18-75 Years
18 to 70 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 4 months ago

What is this trial about?

Ankle sprain is a fairly common sports medicine clinic. In Taiwan at least 150,000 to 200,000 people will suffer from ankle sprains every years. Clinicians have been looking for ways to shorten treatment time and reduce discomfort. Platelet Rich Plasma(PRP) is an endogenous therapeutic technology that involved in regenerative medicine due to its potential to stimulate and accelerate tissue healing. PRP can release lots of growth factors like platelet-derived growth factor (PDGF),transforming Growth Factor Beta(TGF-β), vascular endothelial growth factor(VEGF),Epidermal growth factor(EGF) and insulin-like growth factor (IGF). Its use had been based on the theory that increased autologous platelets, that then yield high concentrations of growth factors and other proteins, will lead to increased healing of tendon and soft tissue on a cellular level. In addition, there is no objective evaluation after treatment, so that patients can not provide effective and accurate quantitative feedback. In this study, the investigators divided patients into three groups, respectively, general rehabilitation therapy, autologous PRP injection therapy, autologous PRP injection combined with general rehabilitation therapy.

What are the participation requirements?

Yes

Inclusion Criteria

- ankle sprain within one months

- Gr II or Gr III ankle sprain (anterior talus fibular ligament)by sonogram proved

- MMSE≥23

- could cooperate the examination of the test

No

Exclusion Criteria

- Hemianopsia or hemineglect any brain lesion such as cerebrum of cerebellum involved movement

- cancer victim

- pregnant If needed PRP treatment

- Liver cirrhosis

- Platelet < 150000/UL

- Sepsis, Leukemia

- use anti-coagulation agents

- under hemodialysis